Fed. Circ. Nixes Boston Scientific Appeal In Stent IP Case
Boston Scientific Corp. will face a trial in a doctor's suit seeking royalties under a license agreement for coronary stent patents, since the Federal Circuit on Tuesday refused to consider the...To view the full article, register now.
Already a subscriber? Click here to view full article